Abstract
A targeted drug delivery system based on AuNPs and DNA was developed to treat neuroblastoma cancer. This system exhibits excellent specificity in delivering and releasing doxorubicin, and has great prospects in clinical applications.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
